Leonard-Meron Biosciences, Inc. Report issue

For profit Phase 3
Founded: Cranford NJ United States (2013)
Status: Acquired by Citius Pharmaceuticals (2016)

Organization Overview

First Clinical Trial
2016
NCT02901717
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Leonard-Meron Biosciences, Inc.